JN
Johnson & Johnson
JNJ · NYSE
$267.69 -0.53% (-$1.44)
1M +5.13%
Market Cap $648.6B
P/E Ratio 30.83x
Div. Yield 2.44%
ROE 25.74%
Bulios Fair Price
$271.48
1.4% upside
Current Price
$267.69
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JNJ is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
33 /100
Expensive P/E 30.83x
EV/EBITDA 20.08x
P/S 6.62x
Growth
57 /100
Stable EPS growth 17.90%
Rev. growth 5.60%
FCF growth 4.65%
Profitability
100 /100
Strong Gross margin 70.45%
Net margin 21.48%
Op. margin 26.81%
Quality
79 /100
Excellent ROIC 13.89%
ROE 25.74%
ROA 10.46%
Debt
81 /100
Low Debt/Equity 0.58x
Current ratio 1.09x
Int. coverage 25.67x
Stability
47 /100
Moderate Beta 0.24x
Rev. volatility 1.15%
EPS volatility 89.73%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JNJ
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
Employees
141,700
Headquarters
New Brunswick
Upcoming events
13 OCT
Earnings
Upcoming earnings report